Most importantly, through further genetic engineering approaches, we demonstrated that miR-153-3p downregulation or CITED2 upregulation could directly reverse the inhibitory effect of FGD5-AS1 downregulation on gastric cancer proliferation and 5-FU chemoresistance. The gene discussed is FGD5; the disease is gastric cancer.